Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense - Plus Therapeutics (NASDAQ:PSTV)
Plus now has $23 million in active awards support for the Company's targeted radiotherapeutic pipeline Funding for pediatric brain cancer treatment is expected to begin in Q3 2024, pending contract finalization
San Antonio United States March Hedrick Charles Huang Cancer Prevention Research Institute Of Texas Research Programs
Source: benzinga.com